The distribution and cellular accumulation, in the rat, of three specifically 14C-labelled forms of streptozotocin were investigated. A significant pancreatic accumulation of radioactivity was observed with (3' -methyl-14C)-streptozotocin only. Autoradiographic studies revealed high levels of bound radioactivity in the islet tissue following the administration of (3 -methyl-14C)-streptozotocin whereas much lower levels of radioactivity were detected in the pancreatic tissue following the administration of either (1-14C)-streptozotocin or (2' -14C)-streptozotocin. In the pancreasea, the amount of radioactivity bound to islet tissue was always significantly higher than that bound to acinar tissue. In addition to the islet tissues, the kidney cortex showed a very high level of bound radioactivity after the administration of (3' -methyl-14C)-streptozotocin. The results suggest that streptozotocin is rapidly metabolised by the rat. The apparent specificity for the accumulation of radiolabel from (3' -methyl-14 C)-streptozotocin suggests that a metabolite derived from the methyl bearing ureido side chain of the drug may be specifically involved in the induction of tissue damage and the consequent development of diabetes.

No abstract

No abstract

No abstract

COVID-19 pneumonia is a recently identified lung infection, the hazardous factor of this pneumonia is pandemic dissemination of infection by corona virus. Due to its high mortality and morbidity it has become a threat to the human life. As pneumonia is the commonest manifestation chest x-ray becomes the primary modality of investigation however many symptomatic patients do not have a positive chest X-ray findings hence, HRCT is used as primary modality for both screening as well as a diagnosing COVID-19 pneumonia. It has been observed that in many situations RT-PCR test are negative or inconclusive but the HRCT in such cases is useful and conclusive. Aim of the article is to highlight the role of HRCT in diagnosing COVID-19 pneumonia and providing proper guidance to the Clinicians for assessing the response and therapeutic purpose for covid19 pneumonia. recently, HRCT score have also been used to provide the clinicians an idea about the Prognosis of this disease progress.